TITLE

Subthalamic deep brain stimulation for advanced Parkinson's disease: all that glitters is not gold

AUTHOR(S)
Linazasoro G; Linazasoro, G
PUB. DATE
June 2003
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jun2003, Vol. 74 Issue 6, p827
SOURCE TYPE
Academic Journal
DOC. TYPE
commentary
ABSTRACT
No abstract available.
ACCESSION #
10631490

 

Related Articles

  • Mild cognitive impairment in Parkinson's disease: millstone or milestone? Burn, David J.; Barker, Roger A. // Practical Neurology (BMJ Publishing Group);Apr2013, Vol. 13 Issue 2, p68 

    The authors discuss the publication of new criteria for the definition of mild cognitive impairment (MCI) in Parkinson's disease (PD). They question whether the new criteria would aid in understanding of PD; they mention that the criteria will be useful only if it offers prognostic value to the...

  • Nociones del deterioro cognitivo leve. Saúl Escobar Cornejo, Guillermo; Ramos-Vargas, Luis F. // Revista Medica Herediana;abr-jun2012, Vol. 23 Issue 2, p134 

    No abstract available.

  • Is the severity of DR predictive of cognitive impairment? Broadbent, Deborah // Diabetes Digest;2013, Vol. 12 Issue 3, p138 

    The article discusses the implication of diabetic retinopathy (DR) to the cognitive impairment of individuals with type 2 diabetes (T2D). It highlights the effectivity on the use of vibration perception threshold (VPT) screening tool for diabetic peripheral neuropathy (DPN). It notes that...

  • Cholinesterase inhibitors should not be prescribed for mild cognitive impairment. Russ, Tom C. // Evidence Based Medicine;Jun2014, Vol. 19 Issue 3, p101 

    The author reflects on the article "Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis" by A.C. Tricco and colleagues, that was published in the 2013 issues of the Canadian Medical Association Journal. Topics discussed...

  • Autonomic failure following deep brain stimulation for Parkinson's disease. Williams, Steven E.; Ernst, Thomas; Birns, Jonathan // British Journal of Hospital Medicine (17508460);Mar2012, Vol. 73 Issue 3, p170 

    The article presents a case study of an 81-year-old with idiopathic Parkinson's disease and asymptomatic orthostatic hypotension who presented with recurrent blackouts. When investigated, significant hypotension was detected and Holter monitoring revealed first degree heart block and pauses. The...

  • Adherence to anti-Parkinson drug therapy in the “REASON” sample of Italian patients with Parkinson’s disease: the linguistic validation of the Italian version of the “Morisky Medical Adherence scale-8 items”. Fabbrini, G.; Abbruzzese, G.; Barone, P.; Antonini, A.; Tinazzi, M.; Castegnaro, G.; Rizzoli, S.; Morisky, D. E.; Lessi, P.; Ceravolo, R. // Neurological Sciences;Nov2013, Vol. 34 Issue 11, p2015 

    Information about patients’ adherence to therapy represents a primary issue in Parkinson’s disease (PD) management. To perform the linguistic validation of the Italian version of the self-rated 8-Item Morisky Medical Adherence Scale (MMAS-8) and to describe in a sample of Italian...

  • Therapy Techniques for Mild Cognitive Impairment. Bourgeois, Michelle S. // Perspectives on Neurophysiology & Neurogenic Speech & Language D;May2013, Vol. 23 Issue 1, p23 

    There is increasing concern among people in late middle age about cognitive changes they experience for everyday memory tasks. They are especially fearful that these memory lapses signal the beginning stages of Alzheimer's disease (AD). For some, the diagnosis of mild cognitive impairment (MCI)...

  • Normal Cognitive Aging and Mild Cognitive Impairment: Drawing the Fine Line. Fleming, Valarie B. // Perspectives on Neurophysiology & Neurogenic Speech & Language D;May2013, Vol. 23 Issue 1, p5 

    Mild cognitive impairment (MCI) is a transitional diagnostic category between normal cognitive aging and dementia. Speech-language pathologists (SLPs) have a role in the management of MCI, particularly the assessment and treatment of cognitive-communicative impairments related to MCI. The...

  • Obsesif Kompulsif Bozuklukta BiliÅŸsel Ä°ÅŸlevler. AYDIN, Pınar Çetinay; ÖYEKÇİN, Demet GÜLEÇ // Turk Psikiyatri Dergisi;Winter2013, Vol. 24 Issue 4, p266 

    Aim: This literature review aimed to examine the relationship between cognitive impairment and obsessive-compulsive disorder (OCD). Studies based on neuropsychological testing were prioritized, but those dealing with clinical features, therapy, comorbidity, neuroimaging, and the families of OCD...

  • Depression can affect patient's understanding of informed consent.  // IRB Advisor;Feb2011, Vol. 11 Issue 2, p21 

    The article suggests to institutional review boards (IRBs) that inpatient depressives may need help in understanding the informed consent procedure. It reveals that among 31 patients, 15 had at least mildly impaired neurocognitive function, thus affecting decision making. Michael Basso, PhD,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics